COMMUNIQUÉS West-GlobeNewswire

Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C
12/10/2026
Additional presentations highlight the design of an ongoing Phase 3 study evaluating tenapanor in chronic idiopathic constipation and the impact of IBS-C symptom burden on quality of life WALTHAM, Mass., Oct. 12, 2026 ( [...]
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia
12/10/2026
Presentations feature real-world experience and clinical evidence in lower-risk MDS, underscoring growing global scientific engagement with imetelstat FOSTER CITY, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Geron [...]
Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026
12/10/2026
Five presentations connect targeted intestinal exposure and sustained systemic drug exposure with PDE4 target engagement and early clinical activity, supporting ongoing Phase 2 development Two presentations selected for [...]
NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness
12/10/2026
Split-adjusted trading to begin on The Nasdaq Capital Market at market open on October 12, 2026 LANGHORNE, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a company with [...]
Kraig Labs Races to Scale Production as Billion-Dollar High-Performance Materials Market Starved for Scalable Supply Beckons
12/10/2026
DENVER, Oct. 12, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com )– Kraig Biocraft Laboratories (OTCQB: KBLB) is making a pivotal move in its push to turn genetically engineered spider silk from a scientific breakthrough [...]
SBC Medical to Present at Cantor Fitzgerald Hong Kong’s Inaugural Asia Longevity Forum
12/10/2026
Yuya Yoshida, Director, CFO and COO, to Present at the Forum in Hong Kong on October 26 and Hold One-on-One Investor Meetings on October 27; Non-Deal Roadshow to Follow on October 28 IRVINE, Calif., Oct. 12, 2026 (GLOBE [...]
Concept Life Sciences Appoints Dr Adrijana Vinter as Chief Executive Officer
12/10/2026
Experienced CRO leader brings deep scientific, commercial and operational expertise to lead the company’s next phase of growth CHAPEL-EN-LE-FRITH, United Kingdom, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Concept Life Sciences [...]
Transactions under Novonesis’ share buyback program
12/10/2026
Please read the announcement in PDF Attachment 2026_21_Share_buyback
Gates Foundation and Wellcome Leap Commit $100 Million to Reduce Global Stillbirth Rates
12/10/2026
Stillbirth affects families everywhere, but the burden is not shared equally: Of the nearly 2 million babies stillborn each year, almost half occur in sub-Saharan Africa New investment will focus on advancing [...]
Aprocitentan efficacy data reinforce endothelin pathway blockade as a distinct therapeutic approach across the cardiometabolic disease spectrum including obesity
12/10/2026
Two oral presentations at AHA Hypertension 2026 demonstrate the pronounced efficacy of aprocitentan in two groups of patients with notoriously difficult to control hypertension from the PRECISION study: patients with [...]
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic Biliary Tract Cancer
12/10/2026
Second FDA Fast Track Designation for Opamtistomig Underscores Its Potential in Immunologically Cold Tumors NANJING, China, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “ [...]
InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China
12/10/2026
BEIJING, Oct. 11, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records
11/10/2026
- In an independent, propensity score-matched analysis of 2,684 individuals living with ATTR-CM from Epic COSMOS, the largest U.S. electronic health record database, acoramidis was associated with a statistically [...]
First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
11/10/2026
SAN DIEGO, Oct. 11, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in [...]
Cardurion Pharmaceuticals Presents Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, as a Novel Treatment for Heart Failure
11/10/2026
In Cycle-1 REF Phase 2 clinical trial, tovinontrine demonstrated substantial reduction in NT-proBNP, a biomarker for heart failure, in patients with HFrEF on top of guideline-directed medical therapy, with a favorable [...]
Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1
11/10/2026
- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1 - 100% of participants who received encaleret reported improvements in at least one ADH1 [...]
Beyond Cholesterol Numbers: Dr. Wallace Brucker Brings AI-Powered Cardiac Plaque Screening to Las Vegas Executives at LV Longevity Lab
11/10/2026
LAS VEGAS, NV, Oct. 11, 2026 (GLOBE NEWSWIRE) -- Using FDA-cleared Cleerly AI analysis of coronary CT angiography, LV Longevity Lab looks directly at the arteries — settling whether plaque exists and personalizing [...]
Claris Biotherapeutics Releases Positive CSB-001 Clinical Proof-of-Concept Data in Limbal Stem Cell Deficiency at AAO 2026 Annual Meeting
11/10/2026
41% of CSB-001 treated eyes gained ≥15 letters compared to 0% in the non-treatment arm 55% of CSB-001 treated eyes gained ≥10 letters compared to 5% in the non-treatment arm Responses were durable, with 50% and 81% of [...]
Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026
11/10/2026
– Significant performance improvement seen across all subtypes of advanced precancerous lesions, which are important to detect for potential colorectal cancer prevention – – Overall detection of colorectal cancer [...]

Pages